Stent in de novo coronary artery lesions. Meat-analysis;Stent en lesiones coronarias de novo. Metaanálisis

Revista Espanola de Cardiologia

Volumn 50, Issue SUPPL. 2, 1997, Pages 3-9

  Masotti, Mónica ^a,b   Serra, Antonio ^a   Betriu, Amadeo ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

Angioplasty Restenosis; Stent

Indexed keywords

ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CORONARY ARTERY DISEASE; FEMALE; HUMAN; MALE; META ANALYSIS; MIDDLE AGED; MORTALITY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; RISK ASSESSMENT; STENT; TREATMENT OUTCOME;

ANGIOPLASTY, BALLOON; CORONARY DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS; RECURRENCE; RISK ASSESSMENT; STENTS; TREATMENT OUTCOME;

EID: 0030627774     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Califf RM, Fortin DF, Frid DJ, Harlan III WR, Ohman EM, Bengtson JR et al. Restenosis after coronary angioplasty: an overview. J Am Coll Cardiol 1991; 17: 2B-13B.
2. Beatt KJ, Serruys PW, Hugenholtz PG. Restenosis after coronary angioplasty: new standards for clinical studies. J Am Coll Cardioll 1990; 66:926-931.
3. Rensing BJ, Hermans WRM, Deckers JW, De Feyter PJ, Tijssen JGP, Serruys PW. Lumen narrowing after percutaneous transluminal coronary balloon angioplasty follows a near gaussian distribution: a quantitative angiographie study in 1,445 successfully dilated lesions. J Am Coll Cardiol 1992; 19: 939-945.
4. Mancini GBJ. Quantitative coronary arteriographic methods in the interventional catheterization laboratory: an update and perspective. J Am Coll Cardiol 1991; 17: 23B-33B.
5. Holmes DR Jr, Vliestra RE, Smith HC, Vetrovec GW, Kent KM, Cowley MJ et al. Restenosis after percutaneous transluminal coronary angioplasty (PTCA): a report from the PTCA registry of the national Heart, Lung, and Blood Institute. Am J Cardiol 1984; 53: 77C-81C.
6. Mata LA, Bosch X, David PR, Rapold HJ, Corcos T, Bourassa MG. Clinical and angiographic assessment 6 months after double vessel percutaneous coronary angioplasty. J Am Coll Cardiol 1985; 6: 1.339-1.344.
7. Ernst SMPG, Van der Feltz TA, Bal ET, Van Gogerijen L, Van der Berg E, Plascoop CA et al. Long term angiographie follow-up, cardiac events, and survival in patients undergoing percutaneous transluminal coronary angioplasty. Br Heart J 1987; 57: 220-225.
8. Serruys PW, Luijten HE, Beatt KJ, Geuskens R, De Feyter PJ, Van den Brand M et al. Incidence of restenosis after successful coronary angioplasty: a time-related phenomenon. A quantitative angiographic study in 342 consecutive patients at 1, 2, 3, and 4 months. Circulation 1988; 77: 361-371.
9. Nobuyoshi M, Kimura T, Nosaka H, Mioka S, Ueno K, Yokoi H et al. Restenosis after successful percutaneous transluminal coronary angioplasty: serial angiographic follow-up of 229 patients. J Am Coll Cardiol 1988; 12: 616-623
10. The Multicenter European Research Trial With Cozapril After Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MERCATOR) Study Group. Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Results of the MERCATOR Study: a multicenter randomized, double-blind placebo-controlled trial. Circulation 1992; 86: 100-110.
11. Thornton MA, Gruentzig AR, Hollman J, King SB III, Douglas JS. Coumadin and aspirin in prevention of recurrence after transluminal coronary angioplasty: a randomized study. Circulation 1984; 69: 721-727.
12. Taylor RR, Gibbons FA, Cope GD, Cumpston GN, Mews GC, Luke P. Effects of low-dose aspirin on restenosis after coronary angioplasty. Am J Cardiol 1991; 68: 874-878.
13. Whitworth HB, Roubin GS, Hollman J, Meier B, Leimgruber PP, Douglas JS et al. Effect of nifedipina on recurrent stenosis after percutanenous transluminal coronary angioplasty. J Am Coll Cardiol 1986; 8: 1.271-1.276.
14. Pepine CJ, Hirschfeld JW, Macdonald RG, Henderson MA, Bass TA, Goldberg S et al. A controlled trial of corticosteroids to prevent restenosis after coronary angioplasty. Circulation 1990; 81: 1.753-1.761.
15. Faxon D, Spiro T, Minor S, Douglas J, Cote G, Dorosti K et al. Enoxaparin, a low molecular weight heparin, in the prevention of restenosis after angioplasty: results of a double blind randomized trial [resumen]. J Am Coll Cardiol 1992; 19 (Supl A): 258.
16. Schwartz L, Bourassa MG, Lespérance J, Aldridge HE, Kazim F, Salvatori VA et al. Aspirin and dipyridamol in the prevention of restenosis after percutaneous transluminal coronary angioplasty. N Engl J Med 1988; 318: 1.714-1.719.
17. Serruys PW, Rutsch W, Heyndrickx GR, Danchin N, Mast EG, Wijns W et al, for the Coronary Artery Restenosis Prevention on repeated Thromboxane-Antagonism Study Group (CARPORT). Prevention of restenosis after percutaneous transluminal coronary angioplasty with thromboxane A2 receptor blockade: a randomized, double blind, placebo-controlled trial. Circulation 1991; 84: 1.568-1.580.
18. Dehmer GJ, Popma JJ, Van den Berg EK, Eichhorm EJ, Prewin JB, Campbell WB et al. Reduction in the rate of early restenosis after coronary angioplasty by a diet supplemented with n-3 fatty acids. N Engl J Med 1988; 319: 733-740.
19. Foley DP, Bonnier H, Jackson G, Macaya C, Shepherd J, Vrolix M et al. Prevention of restenosis after coronary ballon angioplasty: rationale and design of the fluvastatin angioplasty restenosis (FLARE) trial. Am J Cardiol 1994; 73: 50D-61D.
20. Topol EJ, Califf RM, Weisman HF, Ellis SG, Tcheng JE, Worley S et al, for the EPIC investigators. Randomised trial of coronary intervention with antibody against IIb/IIIa integrin for reduction of clinical restenosis: results at six months. Lancet 1994; 343: 881-886.
21. Bittl JA, Sanborn TA. Exicimer laser-facilitated coronary angioplasty: relative risk analysis of acute and follow-up results in 200 patients. Circulation 1992; 86: 71-80.
22. Topol EJ, Leya F, Pinkerton CA, Whitlow PL. Hofling B. Simonton CA et al, for the CAVEAT Study Group. A comparison of directional atherectomy with coronary angioplasty in patients with coronary artery disease. N Engl J Med 1993; 329: 221-227.
23. Adelman AD, Cohen EA, Kimball BP, Bonan R, Ricci DR, Webb JG et al. A comparison of directional atherectomy with balloon angioplasty for lesions of the left anterior descending coronary artery. N Engl J Med 1993; 329: 228-233.
24. Umans VA, Melkert R, Foley DP, Serruys PW. Clinical and angiographic comparison of matched patients with successful directional atherectomy or stent implantation for primary coronary artery lesions. J Am Coll Cardiol 1996; 28: 637-644.
25. Rensing BJ, Hermans WR, Strauss BH, Serruys PW. Regional differences in elastic recoil after percutaneous transluminal coronary angioplasty: a quantitative angiographic study. J Am Coll Cardiol 1991; 17: 34B-38B.
26. Rensing BJ, Hermans WR, Vos J, Bossuyt P, Rutsch P, Serruys PW. Angiographic risk factors of Iuminal narrowing after coronary balloon angioplasty using measurements to reflect streth and elastic recoil at the dilatation size. Am J Cardiol 1992; 69: 584-591.
27. Haude M, Erbel R, Issa H, Meycr J. Quantitative analysis of elastic recoil after ballon angioplasty and after intracoronary implantation of balloon- expandable Palmaz-Schatz stents. J Am Coll Cardiol 1993; 21: 26-34.
28. Serruys PW, Strauss BH, Beat KJ, Bertrand ME, Puel J, Rickards AF et al. Angiographie follow-up after placement of a self-expanding coronary artery stent. N Engl J Med 1991; 324: 13-17.
29. Shatz RA, Goldberg S, Leon M, Bairn D, Hirshfeld J, Cleman M et al. Clinical experience with the Palmaz-Schatz coronary stent. J Am Coll Cardiol 1991; 17: 155B-159B.
30. Kimura T, Nosaka H, Yokoi H, Iwabuchi M, Nobuyoshi M. Serial angiopraphic follow-up after Palmaz-Schatz stent implantation: comparison with conventional balloon angioplasty. J Am Coll Cardiol 1993; 21: 1.557-1.563.
31. Fajadet J, Doubet S, Cassagneu B, Robert G, Caillard JB, Marco J. Palmaz Schatz coronary stenting: single institutional experience of 500 consecutive patients [resumen]. Eur Heart J 1992; 13: 5.
32. Haude M. Erbel R, Straub U, Dietz U, Schatz R, Meyer I et al. Short- and long-term results after intracoronary stenting in human coronary arteries: monocenter experience with the balloon-expandable Palmaz-Schatz stent. Br Heart J 1991; 66: 337-345.
33. Serruys PW, De Jaegere P, Kiemeneij F, Macaya C, Rutsch W. Heyndrickx G et al, on behalf of the Benestent Study Group. A comparison of Balloon-Expandable-Stent Implantation with Balloon Angioplasty in Patients with Coronary Artery Disease. N Egl J Med 1994; 331: 489-495.
34. Fischman DL, Leon MB, Bairn DS, Schatz RA, Savage MP, Penn I et al. A Randomized Comparison of Coronary-Stent Placement and Balloon Angioplasty in the treatment of Coronary Artery Disease. N Engl J Med 1994; 331: 496-501.
35. Betriu A, Serra A, Masotti M, Delcán JL, García E, Colman T et al. Are national randomized trials a necessary evil? J Intervent Cardiol 1994; 7: 347-353.
36. Masotti M, Serra A, Fernández-Avilés F, Alonso J, Gimeno F, Colman T et al. Stent vs Angioplasty restenosis trial (START). Angiographic results at six month follow-up [resumen]. Circulation 1996; 94 (Supl 1): 685.
37. Halvorsen KT. Medical uses of statistics. Massachusets: John C Bailar III. Frederick Mosteller, 1986; 392-415.
38. Michels KB, Yusuf S. Does PTCA in acute myocardial infarction affect mortality and remfarction rates? A quantitative overview (meta-analysis) of the randomized clinical trials. Circulation 1995; 91: 476-485.
39. Lau J, Antman EM, Jiménez-Silva J, Kupelnick B, Mosteller F et al. Cummulative meta-analysis of therapeutic trials for myocardial infarction. N Engl J Med 1992; 327: 248-254.
40. Goldberg SL, Colombo A, Nakamura S, Almagor Y, Maiello L, Tobis JM. Benefit of intracoronary ultrasond in the development of Palmaz-Schatz stents. J Am Coll Cardiol 1994; 24: 996-1.003.
41. Colombo A, Hall P, Nakamura S, Almagor Y, Maiello L, Martini G et al. Intracoronary stenting without anticoagulation accomplished with intravascular ultrasond guidance. Circulation 1995; 91: 1.676-1.688.
42. Morice MC, Zemour G, Benveniste E, Biron Y, Bourdonnec C, Faivre R et al. Intracoronary stenting without coumadin: one month results of a French multicenter study. Cathet Cardiovasc Diagn 1995; 35: 1-7.
43. Morice MC, Bourdonnec C, Lefevre T, Blanchard D, Monnassier JP. Lienhart Y et al. Coronary stenting without coumadin. Phase III [resumen]. Circulation 1994; 90 (Supl 1): 125.
44. Mourice MC, Lefevre T, Aubry P, Monassier JP, Spaulding C, Benveniste E et al. The MUST trial. In-hospital and clinical events at six months [resumen]. Eur Heart J 1996; 17: 460.
45. Lablanche JM, Bonnet JL, Grollier G, Danchin N, Bedossa M, Vahanian A et al. Combined antiplatelet therapy without anticoagulation after stent implantation: The Ticlopidine Aspirin Stent Evaluation (TASTE) study [resumen]. Eur Heart J 1996; 17: 461.
46. Goods CM, Liu MW, Negus BH, Iyer SS, Yadav JS, Al-Shaibi KF et al. A cost analysis of coronary stenting without anticoagulation versus stenting with anticoagulation using warfarin. Am J Cardiol 1996; 78: 334-336.
47. Cohen DJ, Breall JA, Ho KL, Kuntz RE, Goldman L, Baim DS et al. Evaluating the potential cost-effectiveness of stenting as a treatment for symptomatic single-vessel coronary disease: use of a decision-analytic model. Circulation 1994; 89: 1.859-1.872.
48. Doucet S, Fajadet J, Cassagneu B, Roberg G, Jordan C, Marco J. Early occlusion following coronary Palmaz-Schatz stent implantation: frequency and clinical or angiographic predictors [resumen]. Eur Heart J 1992; 13: 4.
49. Halon DA, Merdier A, Shefer A, Flugelman MY, Lewis BS. Identifying patients at high risk for restenosis after percutaneous transluminal coronary angioplasty for unstable angina pectoris. Am J Cardiol 1989; 64: 289-293.
50. Weintraub WS, Kosinski AS, Brown ChL, King SB. Can restenosis after coronary angioplasty be predicted from clinical variables? J Am Coll Cardiol 1993; 21: 6-14.
51. Ellis SG, Roubin GS, King SB III, Douglas JS Jr, Cox WR. Importance of stenosis morphology in the estimation of restenosis risk after elective percutaneous transluminal angioplasty. Am J Cardiol 1989; 63: 30-34.
52. Hirshfeld JW, Schwartz JS, Jugo R, McDonald RG, Goldberg S, Savage MP et al, and the M-Heart Investigators, Restenosis after coronary angioplasty: a multivariate statistical model to relate lesion and procedure variables to restenosis. J Am Coll Cardiol 1991; 18: 647-656.